SG Blocks Subsidiary Chicago Area Testing Deploys Medical Unit
SG Blocks (NASDAQ: SGBX) has announced an agreement with Robbins Park District to deploy a COVID-19 testing medical unit in Robbins, Illinois. The initiative aims to provide essential testing services to underserved communities in the South suburbs of Chicago, which are experiencing high unemployment and positivity rates. Testing is scheduled to begin around June 8th, offering various tests such as rapid antigen and PCR tests. This agreement marks the first step in SG Blocks’ strategy to expand healthcare access through modular medical units.
- Partnership with Robbins Park District to enhance COVID-19 testing access.
- First modular medical unit to serve underserved areas, potentially leading to further expansion.
- Testing services scheduled to commence on June 8th, providing rapid antigen and PCR tests.
- Dependence on the successful deployment of the testing unit as planned.
- Uncertainty in future profitability and maintaining NASDAQ compliance.
SG Blocks, Inc. (NASDAQ: SGBX) (“SG Blocks” or the “Company”), a leading designer, innovator and fabricator of container-based structures, announced today an agreement between the Robbins Park District and the Company’s Chicago Area Testing, Inc. subsidiary to deploy a COVID-19 testing medical unit in the town of Robbins, Illinois. The agreement between the Robbins Park District and Chicago Area Testing aims for the provision of critical COVID testing in underserved communities within the South suburbs of Chicago.
Robbins Park District, Illinois, proposed site of COVID-19 testing medical unit. (Photo: Business Wire)
The agreement is a result of the partnership between National Pain Centers and SG Blocks, a collaboration that has led to the formation and creation of Chicago Area Testing. The community in Robbins was selected based on the grave health conditions and lack of COVID testing facilities within a ten-mile radius. A majority of the community has little to no access to adequate health care and services and represents a vulnerable population hit by the recent pandemic with high rates of unemployment and positivity rates.
“We couldn’t be more pleased to work with Dr. Jay Joshi and his team to reach an agreement with the Robbins Park District to provide COVID-19 testing to an underprivileged area that is in need of quality and accessible medical care,” Paul Galvin, Chairman & CEO of SG Blocks noted. “We are happy to provide our pop-up medical unit, and we look forward to exploring other diagnostic testing capabilities via these modules, as we know that there is use for this kind of point-of-care access well beyond COVID-19.”
This unit will be the first of what the Company hopes are many modules to bring testing into underrepresented areas.
“We are working to reduce the barrier of transportation and accessibility, so Illinoisans have easy access to testing/surveillance services,” Dr. Jay Joshi, CEO of Chicago Area Testing noted. “COVID-19 is a public health crisis, and it is crucial that we ensure quality healthcare, especially during the time of COVID-19, is easily available and affordable.”
Testing is expected to become available on or about June 8th weekly Tuesday to Saturdays, at 13650 S Claire Blvd, Robbins, IL 60472, with rapid antigen tests, rapid antibody tests, and fast PCR tests (results within 12 hours) accessible, in addition to other lab diagnostic screenings as needed by the community.
About SG Blocks, Inc.
SG Blocks, Inc. is a premier innovator in advancing and promoting the use of code-engineered cargo shipping containers for safe and sustainable construction. The firm offers a product that exceeds many standard building code requirements, and also supports developers, architects, builders and owners in achieving greener construction, faster execution, and stronger buildings of higher value. Each project starts with GreenSteel™, the structural core and shell of an SG Blocks building, and then is customized to client specifications. For more information, visit www.sgblocks.com.
About National Pain Centers
National Pain Centers was founded with the belief that all medical services should be delivered with the highest quality standard of care available. National Pain Centers has acquired recognition and respect locally and nationally for their top-tier Interventional Spine and Pain diagnosis and treatment incorporating a multimodal and logical approach with individualized care. Jay Joshi, MD, DABA, DABAPM, FABAPM, the CEO and Medical Director, is a nationally recognized double board certified Anesthesiologist and Interventional Spine and Pain Management physician who has led with pioneering work in PTSD, CRPS, regenerative medicine, anti-counterfeiting, and COVID testing. For more information, visit www.nationalpain.com.
Safe Harbor Statement
Forward-Looking Statements Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements regarding plans to deploy a COVID-19 testing site in Robbins, Illinois, exploring other diagnostic testing capabilities via these modules and testing becoming available on or about June 8th. While SG Blocks believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company’s ability to deploy the COVID-19 testing site in Robbins, Illinois as planned, the Company’s ability to explore other diagnostic testing capabilities via its modules, the Company’s ability to position itself for future profitability, the Company’s ability to maintain compliance with the NASDAQ listing requirements, and the other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210525005337/en/
FAQ
What testing services will SG Blocks provide in Robbins, Illinois?
When will COVID-19 testing start in Robbins, Illinois?
What is the significance of the partnership between SG Blocks and Robbins Park District?
How does SG Blocks plan to expand its healthcare services?
What has led to the establishment of the Chicago Area Testing unit?
